
DoAI builds AI-driven diagnostic algorithms to detect disease from medical images and pathology, with a focus on early-stage cancer detection. The company combines deep learning with Nano-Raman spectroscopy and image analysis to create automated diagnostic models for radiology, pathology, pharma research, and genomics applications. DoAI operates as a healthcare AI vendor (B2B) delivering software and algorithmic solutions that integrate with clinical workflows and laboratory imaging systems. Its offerings target diagnostic labs, hospitals, and pharmaceutical researchers focused on early pancreatic cancer and other oncology use cases.

DoAI builds AI-driven diagnostic algorithms to detect disease from medical images and pathology, with a focus on early-stage cancer detection. The company combines deep learning with Nano-Raman spectroscopy and image analysis to create automated diagnostic models for radiology, pathology, pharma research, and genomics applications. DoAI operates as a healthcare AI vendor (B2B) delivering software and algorithmic solutions that integrate with clinical workflows and laboratory imaging systems. Its offerings target diagnostic labs, hospitals, and pharmaceutical researchers focused on early pancreatic cancer and other oncology use cases.